Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enviri
NVRI
|
+$21.2M |
| 2 |
THS
Treehouse Foods
THS
|
+$19.6M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
+$19M |
| 4 |
OPB
Opus Bank Common Stock
OPB
|
+$13.8M |
| 5 |
Merit Medical Systems
MMSI
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFII
Electronics for Imaging
EFII
|
+$57.1M |
| 2 |
HEICO Corp Class A
HEI.A
|
+$16.5M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$9.91M |
| 4 |
Casella Waste Systems
CWST
|
+$6.15M |
| 5 |
Euronet Worldwide
EEFT
|
+$6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.5% |
| 2 | Financials | 14.47% |
| 3 | Technology | 14.45% |
| 4 | Healthcare | 11.13% |
| 5 | Consumer Discretionary | 9.11% |
Similar funds
Aristotle Capital Boston's Q3 2019 Portfolio in Review
As of Q3 2019, Aristotle Capital Boston held 129 positions worth $3.41B, up 6.5% from $3.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aristotle Capital Boston deployed $293M of net new capital in Q3 2019, opening 4 new positions and adding to 103 existing holdings. Its largest new stake was Treehouse Foods: 358,099 shares worth $19.9M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was HEICO Corp Class A, an estimated $16.5M trimmed.
- Aristotle Capital Boston's largest Q3 2019 buy was Treehouse Foods: 358,099 shares worth $19.9M.
- Aristotle Capital Boston added most to Enviri in Q3 2019, an estimated $21.2M increase.
- Aristotle Capital Boston's biggest Q3 2019 reduction was HEICO Corp Class A, cutting an estimated $16.5M.
- Aristotle Capital Boston fully exited Electronics for Imaging in Q3 2019, selling an estimated $57.1M.
- Aristotle Capital Boston's ten largest holdings make up 19% of its $3.41B portfolio in Q3 2019.
- Aristotle Capital Boston opened 4 new positions and closed 1 in Q3 2019.
- Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $3.41B.
Based on Aristotle Capital Boston's 13F filing for Q3 2019, filed 14 Nov 2019.